Sign in

CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831476348
Phone
(619) 728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
  1. 4 Open-market sale Director sold 138,711 shares at an average $16.46 ($2,282,656)
  2. 4 Open-market buy Chief Financial Officer bought 9,500 shares at $16.00 ($151,954)
  3. 4 Returned to the company See remarks returned 2,000,000 shares (to the company)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale President and CEO sold 62,720 shares at an average $27.28 ($1,711,247)
  6. 4 Other disposition Director disposed of 1,000,000 shares (other)
  7. 4 Planned sale President and CEO sold 58,726 shares at an average $25.77 ($1,513,271)
  8. 4 Planned sale President and CEO sold 500 shares at $24.00 ($12,000)
  9. 4 Planned sale President and CEO sold 11,747 shares at an average $24.11 ($283,223)
  10. 4 Planned sale President and CEO sold 16,307 shares at an average $24.19 ($394,441)
  11. 4 Grant or award President and CEO acquired 1,350 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 954 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Option exercise Director acquired 61,392 shares (option exercise)
  19. 4 Planned sale Chief Operating Officer sold 3,702 shares at an average $20.00 ($74,045)
  20. 4 Derivatives Options or other derivatives

Page 4 of 11 · 203 filings